Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/CELGENE-8736/news/Celgene-REVLIMID-Lenalidomide-Approved-by-the-European-Commission-for-the-Treatment-of-Relapse-22699620/?utm_source=whatsapp&utm_medium=social&utm_campaign=share